A liver-targeted copper supplement reduced fat buildup in the liver by activating fat breakdown and burning pathways in laboratory studies and mice with fatty liver disease, according to Gram Research analysis of a 2026 preprint study. The copper worked by blocking an enzyme that normally prevents fat-burning, while simultaneously enhancing the liver’s ability to burn fatty acids for energy. However, these findings are preliminary and have not yet been tested in human clinical trials, so copper supplementation is not yet recommended as a treatment for fatty liver disease.
Researchers have discovered that a special copper supplement designed to target the liver may help reduce fatty liver disease by changing how the body processes fat. According to Gram Research analysis, the study found that copper deficiency plays a role in metabolic dysfunction-associated liver steatosis (MASLD), a common condition where fat builds up in the liver. When scientists gave liver-targeted copper supplements to mice and analyzed tissue samples from patients, they found that copper helps the liver break down and burn stored fat more efficiently. This discovery could lead to a new treatment approach for millions of people with fatty liver disease.
Key Statistics
A 2026 preprint study found that liver-targeted copper supplementation reduced fat accumulation in mice with diet-induced fatty liver disease by activating dual pathways of fat breakdown and fatty acid oxidation.
Research analysis identified that copper deficiency is a nutrient vulnerability in metabolic dysfunction-associated liver steatosis (MASLD), with widespread alterations in hepatic copper homeostasis markers observed in both patient and mouse tissue samples.
The study demonstrated that copper inhibits PDE3B enzyme activity, which activates PKA-mediated fat-burning proteins HSL and AMPK, creating a multi-pronged mechanism to rewire lipid metabolism in steatotic liver disease.
Copper supplementation enhanced mitochondrial fatty acid oxidation and oxidative phosphorylation efficiency in liver cells, with increased activity of copper-dependent complex IV and SOD1 proteins supporting energy production.
The Quick Take
- What they studied: Whether a special copper supplement designed to work specifically in the liver could reduce fat buildup in the liver and how it would work at the cellular level.
- Who participated: The research involved tissue samples from patients with fatty liver disease and laboratory mice that were fed high-fat diets to develop fatty liver disease. The exact number of human participants was not specified in the preprint.
- Key finding: Liver-targeted copper supplementation reduced fat accumulation in the liver by activating two key processes: breaking down stored fat droplets and burning fatty acids for energy through enhanced mitochondrial function.
- What it means for you: This research suggests a potential new treatment for fatty liver disease, though it’s still in early stages. The findings are promising but need to be tested in human clinical trials before copper supplements can be recommended as a standard treatment.
The Research Details
This was a laboratory research study that combined multiple analytical approaches to understand how copper affects liver fat metabolism. The researchers examined tissue samples from patients with fatty liver disease and compared them to healthy tissue, looking for differences in how copper is handled in the liver. They then conducted experiments in mice with diet-induced fatty liver disease, giving some mice a specially designed copper supplement that targets the liver specifically. The team used advanced molecular techniques to track what happens inside liver cells when copper levels are increased, identifying the specific proteins and pathways involved in fat breakdown and burning.
The research employed what scientists call “multi-omics” analysis, which means they looked at the problem from multiple angles simultaneously—examining genes, proteins, and cellular energy production. This comprehensive approach allowed them to map out the complete chain of events triggered by copper supplementation, from the initial signal in the cell to the final breakdown of fat molecules.
This research approach is important because fatty liver disease is extremely common but has limited treatment options beyond lifestyle changes. By identifying a specific nutrient deficiency and showing how it contributes to the disease, the researchers have opened a new avenue for treatment. The multi-level analysis they used provides strong evidence that copper’s effects are real and not just coincidental, making it more likely that this could translate into an actual treatment for patients.
This study was published as a preprint, meaning it has not yet undergone formal peer review by independent experts. While the research appears comprehensive and uses sophisticated molecular techniques, readers should understand that preprint findings require confirmation through peer review and human clinical trials before they can be considered established medical fact. The study was conducted in laboratory settings and mice, which don’t always translate directly to how treatments work in humans.
What the Results Show
The research revealed that people and mice with fatty liver disease have abnormal copper levels and altered copper-handling systems in their liver cells. When researchers gave liver-targeted copper supplements to mice with fatty liver disease, the amount of fat stored in the liver decreased significantly. The copper worked by activating a cascade of cellular signals that told fat cells to break apart and release their stored fat. Once released, these fatty acids were transported into the mitochondria (the cell’s energy factories) where they were burned for energy rather than being stored.
The mechanism involved several key steps: copper inhibited an enzyme called PDE3B, which normally prevents the activation of a fat-burning pathway. By blocking this enzyme, copper allowed another protein called PKA to become active, which then activated two important fat-burning proteins called HSL and AMPK. These proteins work together to break down the lipid droplets that store fat in liver cells. Simultaneously, copper enhanced the liver cell’s ability to burn fatty acids by boosting the activity of mitochondrial proteins involved in energy production, particularly a copper-dependent protein called complex IV.
The research also found that copper supplementation downregulated CD36, a protein that normally brings fatty acids into liver cells. By reducing this fatty acid importer while simultaneously increasing fat breakdown and burning, the copper supplement created a dual effect that reduces fat accumulation. Additionally, the study showed that copper enhanced oxidative phosphorylation, which is the most efficient way for cells to produce energy from nutrients. This energetic rewiring means that the liver becomes better at converting fat into usable energy rather than storing it.
This research builds on earlier observations that copper deficiency exists in people with fatty liver disease, but it goes much further by explaining exactly how copper deficiency contributes to the problem and demonstrating that supplementation can reverse it. Previous studies have suggested that various nutrients play roles in liver health, but this is among the first to identify copper as a key regulator of the specific pathways that control fat breakdown and burning in the liver. The findings suggest that copper’s role in liver disease has been overlooked in previous research.
This study has several important limitations. First, it was conducted primarily in laboratory mice, and results in mice don’t always translate to humans due to differences in metabolism and physiology. Second, the research used a specially designed liver-targeted copper supplement that may not be the same as copper supplements available to consumers. Third, the study examined tissue samples from patients but didn’t conduct a full clinical trial in humans to test whether the supplement actually works in real people. Fourth, the exact number of human tissue samples analyzed was not specified. Finally, the study was published as a preprint and has not yet undergone formal peer review by independent experts, which is a standard quality check in medical research.
The Bottom Line
Based on this research, copper supplementation shows theoretical promise for fatty liver disease, but it is far too early to recommend it as a treatment. The findings are preliminary and based on laboratory and animal studies. Anyone with fatty liver disease should continue following established recommendations: maintain a healthy weight, limit sugar and processed foods, exercise regularly, and work with their healthcare provider. Do not start taking copper supplements specifically for fatty liver disease without consulting a doctor, as excess copper can be toxic. Wait for human clinical trials to confirm these findings before considering supplementation.
People with metabolic dysfunction-associated liver steatosis (MASLD) or fatty liver disease should be aware of this research as a potential future treatment option. Healthcare providers treating liver disease should monitor this research as it develops. People considering copper supplementation should be cautious, as the optimal dose and delivery method for humans remain unknown. Those with copper metabolism disorders or taking medications that interact with copper should definitely consult their doctor before considering any copper supplement.
If this research leads to human clinical trials, it will likely take 3-5 years before results are available. Even if trials are successful, regulatory approval and availability of a liver-targeted copper supplement could take several additional years. Realistic expectations are that any new treatment based on this research would not be widely available for at least 5-10 years.
Frequently Asked Questions
Can I take copper supplements to treat my fatty liver disease?
Not yet. While this 2026 research shows promise in laboratory studies and mice, human clinical trials have not been conducted. Standard treatment remains weight loss, reduced sugar intake, and exercise. Consult your doctor before taking any copper supplement, as excess copper can be harmful.
How does copper help reduce liver fat?
Copper activates fat-burning pathways in liver cells by blocking an enzyme that normally prevents fat breakdown, while simultaneously enhancing the liver’s ability to burn fatty acids for energy. This dual mechanism reduces fat storage in the liver.
Is copper deficiency common in people with fatty liver disease?
According to this 2026 research, copper deficiency appears to be a nutrient vulnerability in fatty liver disease, with altered copper handling observed in patient tissue samples. However, more research is needed to understand how common this deficiency is.
When will copper supplements be available as a treatment for fatty liver disease?
If human clinical trials confirm these findings, it could take 5-10 years or more before a liver-targeted copper supplement becomes available as an approved treatment. This research is still in early stages and requires peer review and human testing.
What should I do now if I have fatty liver disease?
Focus on proven strategies: maintain a healthy weight, limit sugar and processed foods, exercise regularly, minimize alcohol, and work with your healthcare provider. Monitor liver health through regular lab tests and ultrasounds. Stay informed about emerging treatments like this copper research.
Want to Apply This Research?
- Users with fatty liver disease could track liver health markers through their healthcare provider’s lab results, specifically monitoring ALT and AST enzymes (which indicate liver damage) and ultrasound findings showing liver fat content. Record these values quarterly to monitor trends over time.
- While awaiting clinical trials, users can implement evidence-based lifestyle changes: log daily intake of copper-rich foods (nuts, seeds, shellfish, dark chocolate), track weekly exercise minutes, monitor alcohol consumption (keep it minimal), and record weight changes. These actions address known risk factors for fatty liver disease.
- Create a long-term health dashboard tracking: monthly weight, quarterly liver enzyme labs (ALT, AST), semi-annual ultrasound results if available, and daily lifestyle factors (exercise, diet quality, alcohol use). Set reminders for regular doctor visits to monitor liver health progression and discuss any new treatments as they become available.
This article discusses preliminary research published as a preprint that has not undergone formal peer review. The findings are based on laboratory studies and animal models, not human clinical trials. Copper supplementation for fatty liver disease is not currently an established medical treatment. Do not start taking copper supplements based on this research without consulting your healthcare provider, as excess copper can be toxic and may interact with medications or underlying health conditions. If you have fatty liver disease, continue following your doctor’s recommendations and evidence-based lifestyle modifications. This information is for educational purposes only and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.